title: [Hodgkin disease and amyloidosis].
authors.affiliation: HYKS:n sädehoidon ja syöpätautien klinikka, Helsinki.
authors.forename: A
authors.initials: A
authors.lastname: Jekunen
authors.forename: A
authors.initials: A
authors.lastname: Maiche
authors.forename: P
authors.initials: P
authors.lastname: Laurila
authors.forename: K
authors.initials: K
authors.lastname: Franssila
authors.forename: I
authors.initials: I
authors.lastname: Elomaa
mesh_terms: D000328:Adult; D000686:Amyloidosis / Q000150:complications* / Q000188:drug therapy; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001761:Bleomycin / Q000008:administration & dosage; D003606:Dacarbazine / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D006689:Hodgkin Disease / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D008297:Male; D008466:Mechlorethamine / Q000008:administration & dosage; D011241:Prednisone / Q000008:administration & dosage; D011344:Procarbazine / Q000008:administration & dosage; D014747:Vinblastine; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D001761:Bleomycin; D011344:Procarbazine; D008466:Mechlorethamine; D014750:Vincristine; D014747:Vinblastine; D003606:Dacarbazine; D004317:Doxorubicin; D011241:Prednisone